Search

everythinglearnresearchcommunity

for

Search:↓

Classical PCOS types A and B are most common and linked to higher health risks.

Treating hyperprolactinemia can help manage PCOS symptoms.

Most women with Polycystic Ovary Syndrome (PCOS) have skin issues like excessive hair, acne, or hair loss. Hormone imbalances are common, and age, certain hormones, and hormone ratios can predict acne. Obesity, infertility, and high cholesterol are also common in these women.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Menopause can cause hair thinning and texture changes due to hormonal and metabolic shifts.

Underweight women with PCOS can have insulin resistance, and treatment with metformin and dexamethasone can improve symptoms.

Agaricus subrufescens improves ovarian function and biochemical health in rats with PCOS.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Lower zinc levels may predict less effective hair loss treatment.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Finasteride helps reduce blood vessel growth in diabetic rat kidneys.

Low ferritin levels can indicate iron deficiency as a cause of hair loss.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Finasteride and metformin both help treat PCOS, but using them together works best.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.